Trastuzumab in the adjuvant treatment of breast cancer

被引：0
|
作者：
Svetlovska, D. [1 ]
Mardiak, J. [1 ,2 ]
Kristova, V [2 ]
机构：
[1] Natl Canc Inst, SK-83310 Bratislava 37, Slovakia
[2] Comenius Univ, Fac Med, Bratislava 81806, Slovakia
来源：
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2007年 / 108卷 / 02期
关键词：
adjuvant treatment; breast cancer; trastuzumab; HER2;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Four large randomized trials to assess efficacy and toxicity of trastuzumab in adjuvant systemic therapy of breast cancer have been initiated. Results clearly demonstrate, that adjuvant treatment of trastuzumab significantly improves outcomes for women with HER2 positive breast cancer. The clinically most significant adverse events of trastuzumab are serious-infusion related reactions and cardiotoxicity. Benefit for patient should be considered according to advantage versus risk.
引用
收藏
页码：100 / 103
页数：4
相关论文
共 50 条
  • [1] Adjuvant Trastuzumab Treatment without Adjuvant Chemotherapy in Early Breast Cancer
    Dall, P.
    Koch, T.
    Lenzen, G.
    Kuhn, T.
    Hielscher, C.
    Reichert, D.
    Maasberg, M.
    Ehscheidt, P.
    Eustermann, H.
    Fischer, G.
    [J]. CANCER RESEARCH, 2011, 71
  • [2] Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab
    Smith, I
    [J]. ANNALS OF ONCOLOGY, 2001, 12 : 75 - 79
  • [3] Adjuvant trastuzumab in early breast cancer
    Mariani, G.
    Gianni, L.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : X54 - X58
  • [4] Irreversible cardiotoxicity after adjuvant treatment with trastuzumab in a case of breast cancer
    Bordin, Paolo
    Volpe, Carla
    Adami, Gianna
    Moretti, Valentino
    Ermacora, Paola
    [J]. TUMORI, 2008, 94 (05) : 777 - 778
  • [5] Concurrent trastuzumab and radiation therapy (RT) in the adjuvant treatment of breast cancer
    Bellon, JR
    Gover, MT
    Burstein, HJ
    Harris, JR
    Harris, LN
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S55 - S56
  • [6] Ongoing adjuvant trials with trastuzumab in breast cancer
    Tan, AR
    Swain, SM
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (05) : 54 - 64
  • [7] Trastuzumab in combination with docetaxel or vinorelbine as adjuvant treatment of breast cancer: the FinHer Trial
    Joensuu, H
    Kellokumpu-Lehtinen, PL
    Bono, P
    Alanko, T
    Kataja, V
    Asola, R
    Utriainen, T
    Kokko, R
    Blanco, G
    Isola, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S5 - S5
  • [8] Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
    Ishihara, Mikiya
    Mukai, Hirofumi
    Nagai, Shunji
    Mukohara, Toru
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 431 - 435
  • [9] Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer - A lifetime model
    Millar, J. Alasdair
    Millward, Michael J.
    [J]. PHARMACOECONOMICS, 2007, 25 (05) : 429 - 442
  • [10] Effect of adjuvant concomitant treatment with radiotherapy and trastuzumab on cardiotoxicity in patients with breast cancer
    Tanja, M.
    Borstnar, S.
    Blagus, R.
    Dolenc, J.
    Bilban-Jakopin, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S302 - S302
12345